Trial intelligence / Profile preview

Acute Effects of Inhaled Budesonide in COPD

NCT00202189Phase 4Completed

Sponsor
Queen's University
Start
Sep 2005
Primary completion
Nov 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Queen's University. Started Sep 2005; status: completed.

02

Drugs

budesonide
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT00202189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00202189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call